A nullimorphic ERLIN2 mutation defines a complicated hereditary spastic paraplegia locus (SPG18)
Open Access
- 28 July 2011
- journal article
- research article
- Published by Springer Nature in neurogenetics
- Vol. 12 (4) , 333-336
Abstract
Hereditary Spastic Paraplegia (HSP) is a clinically and genetically heterogeneous group of neurological disorders that are characterized by progressive spasticity of the lower extremities. We describe an extended consanguineous Saudi family in which HSP is linked to SPG18, a previously reported autosomal recessive locus, and show that it is associated with a nullimorphic deletion of ERLIN2, a component of endoplasmic reticulum associated degradation. This finding adds to the growing diversity of cellular functions that are now known to be involved in the maintenance of the corticospinal tract neurons.Keywords
This publication has 11 references indexed in Scilit:
- A frameshift mutation of ERLIN2 in recessive intellectual disability, motor dysfunction and multiple joint contracturesHuman Molecular Genetics, 2011
- Hereditary spastic paraplegias: membrane traffic and the motor pathwayNature Reviews Neuroscience, 2010
- Autozygome decodedGenetics in Medicine, 2010
- An Endoplasmic Reticulum (ER) Membrane Complex Composed of SPFH1 and SPFH2 Mediates the ER-associated Degradation of Inositol 1,4,5-Trisphosphate ReceptorsJournal of Biological Chemistry, 2009
- Hereditary spastic paraplegia: clinical features and pathogenetic mechanismsThe Lancet Neurology, 2008
- One step at a time: endoplasmic reticulum-associated degradationNature Reviews Molecular Cell Biology, 2008
- The SPFH domain-containing proteins: more than lipid raft markersTrends in Cell Biology, 2007
- SPFH2 Mediates the Endoplasmic Reticulum-associated Degradation of Inositol 1,4,5-Trisphosphate Receptors and Other Substrates in Mammalian CellsJournal of Biological Chemistry, 2007
- A novel locus for hereditary spastic paraplegia with thin corpus callosum and epilepsyNeurology, 2006
- Regulated ubiquitination of proteins in GPCR-initiated signaling pathwaysTrends in Pharmacological Sciences, 2004